| Section | Status | CDF | Name |
| 08.01.05 | Formulary |  |
Atezolizumab Tecentriq® |
| 08.01.05 | Formulary | |
Avelumab Bavencio® |
| 08.01.05 | Restricted Use | |
Axicabtagene ciloleucel YESCARTA® |
| 08.01.01 | Formulary | |
Bendamustine Levact® |
| 08.01.05 | Formulary | |
Bevacizumab Avastin® |
| 08.01.05 | Formulary | |
Binimetinib Mektovi® |
| 08.01.05 | Formulary | |
Bortezomib Velcade® |
| 08.01.05 | Formulary | |
Brigatinib Alunbrig® |
| 08.01 | Formulary | |
Cabozantinib Cometriq® |
| 08.01.03 | Formulary | |
Clofarabine Evoltra® |
| 08.01.05 | Formulary | |
Crizotinib Xalkori® |
| 08.01.05 | Formulary | |
Daratumumab DARZALEX® |
| 08.01.02 | Formulary | |
Doxorubicin Hydrochloride Caelyx® |
| 08.01.05 | Formulary | |
Encorafenib Braftovi® |
| 08.01.05 | Formulary | |
Ibrutinib Imbruvica® |
| 08.01.05 | Formulary | |
Ixazomib Ninlaro® |
| 08.01.05 | Formulary | |
Lenvatinib Kisplyx®, Lenvima® |
| 08.01.05 | Formulary | |
Liposomal Cytarabine-Daunorubicin Vyxeos® |
| 08.01.05 | Formulary | |
Lutetium (177Lu) oxodotreotide Lutathera® |
| 08.01.03 | Formulary | |
Nelarabine Atriance® |
| 08.01.05 | Formulary | |
Niraparib Zejula® |
| 08.01.05 | Formulary | |
Nivolumab Opdivo® |
| 08.02.03 | Formulary | |
Obinutuzumab Gazyvaro® |
| 08.01.05 | Restricted Use | |
Olaratumab Lartruvo® |
| 08.01.05 | Formulary | |
Osimertinib Tagrisso® |
| 08.01.05 | Formulary | |
Pembrolizumab Keytruda® |
| 08.01.05 | Formulary | |
Pertuzumab Perjeta® |
| 08.01.05 | Formulary | |
Sorafenib Nexavar® |
| 08.01.05 | Restricted Use | |
Tisagenlecleucel Kymriah® |
| 08.01.05 | Formulary | |
Trametinib Mekinist® |
| 08.01.05 | Non Formulary | |
Vandetanib Caprelsa® |
| 08.01.05 | Formulary | |
Venetoclax Venclyxto® |